ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Victoza for Type 2 Diabetes in Children and Adolescents americanpharmaceuticalreview
June 21, 2019Novo Nordisk announced the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Victoza? (liraglutide) injection to lower blood sugar along with diet and exercise in children and adolescents aged 10-17 years with type 2 diabetes
Pharma Sources Insight January 2025
